Related Experiment Video

Updated: Jun 23, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

Pharmacological inhibition of aurora-A but not aurora-B impairs interphase microtubule dynamics

Corinne Lorenzo1, Qiaoyin Liao, Mary Ann Hardwicke

  • 1Université de Toulouse, LBCMCP, Toulouse, France.

Cell Cycle (Georgetown, Tex.)
|April 28, 2009
PubMed

Insights

Specific inhibition of Aurora-A kinase disrupts microtubule dynamics by decreasing growth and nucleation. This finding highlights Aurora-A

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Aurora kinases are crucial regulators of cell division.
  • They are actively pursued as therapeutic targets in oncology.
  • Understanding their role in interphase is vital for cancer treatment.

Purpose of the Study:

  • To investigate the impact of specific Aurora-A and Aurora-B inhibition on interphase microtubule dynamics.
  • To elucidate the role of Aurora-A in microtubule regulation during interphase.

Main Methods:

  • Utilized specific inhibitors GSK6000063A (Aurora-A) and AZD1152 HQPA (Aurora-B).
  • Employed video microscopy and laser-based photoablation techniques.
  • Analyzed microtubule dynamics including growth, shrinkage, rescue frequency, and nucleation.

Main Results:

  • Aurora-A inhibition led to significant microtubule network disorganization and bundling.
  • Specific inhibition of Aurora-A decreased microtubule shrinkage, growth rate, rescue frequency, and nucleation.
  • Aurora-B inhibition effects on interphase microtubule dynamics were also assessed (though not detailed in the provided text).

Conclusions:

  • Aurora-A plays a significant role in regulating microtubule dynamics during interphase.
  • Targeting Aurora-A may offer novel therapeutic strategies for cancer by disrupting microtubule organization.
  • Further research into Aurora-A's interphase functions is warranted for pharmacological applications.

More Related Videos

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations07:14

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations

Published on: September 20, 2019

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...